Research Brings New Hope for Mesothelioma Patients

In New York, the family of a merchant marine who died of malignant mesothelioma caused by exposure to asbestos has won the right to sue Chevron.
In New Jersey, a man suffering malignant mesothelioma is suing Johnson & Johnson for failing to keep their talc-based baby powder – which he regularly used – from being contaminated with asbestos. 
And in Washington, DC, the Supreme Court has ruled that manufacturers have a duty to warn about the potential dangers of parts containing asbestos in a case which started with a suit by two Navy veterans, both of whom developed cancer.

The link between mesothelioma and asbestos is impossible to ignore. In thousands of lawsuits nationwide, our clients and many others diagnosed with cancer caused by asbestos exposure charge that employers like Chevron and manufacturers like Johnson & Johnson ignored repeated warnings about asbestos.

Thinking Outside the Box: Inhalable Cancer Treatment 
There is, however, some good news for those suffering from the effects of asbestos exposure. Because mesothelioma is so difficult to treat, cancer researchers are thinking outside the box to find better methods of treatment. One of the most promising approaches is a new medication that relies on inhaling “messenger RNA molecules.”
RNA, which stands for ribonucleic acid, is present in all living cells. It acts as a messenger, carrying instructions for controlling protein synthesis. MIT researchers recognized that messenger RNA molecules would be highly effective in delivering genetic instructions to the lung’s cells to fight back against cancer.
Developing a formula containing messenger RNA molecules, the researchers then took their work a step further. They believed that inhaling their new formula would be a more effective way of ensuring that the drug would be fully delivered to the lungs and would have the maximum possible impact.
After testing their inhalable treatment on laboratory mice, the researchers concluded they were right. It was highly effective in treating not just mesothelioma, but all types of lung cancer. This development potentially could be a game-changer in treating individuals suffering from mesothelioma.
If You Are Suffering from Cancer Caused by Asbestos …
Patients and physicians alike will be closely watching this and other new approaches to treating mesothelioma and other asbestos-related diseases. If you or a loved one are suffering from cancer which you suspect may have been caused by asbestos exposure, contact our experienced asbestos attorneys today. All consultations are free and you pay nothing unless we win. Call 800-794-0444 today.
The post Research Brings New Hope for Mesothelioma Patients appeared first on Pintas & Mullins Law Firm.

Komentar

Posting Komentar

Postingan populer dari blog ini

New Hope for Patients with Relapsed Mesothelioma

Every year, cancer doctors and researchers from around the country meet to discuss the latest in cancer care and treatment. This year, speakers presented a new hope for patients with relapsed mesothelioma: immunotherapy. The study focused on patients with malignant pleural mesothelioma (MPM), which affects the lining of the lungs. Patients involved in the study had relapsing MPM. Read more about pleural mesothelioma Currently, chemotherapy, surgery, or radiation (or a combination of the three) are the top methods for treating mesothelioma. Immunotherapy uses a person’s own immune system to fight cancer. MESO PATIENTS OPT-IN TO STUDY, WITH PROMISING RESULTS For the study, researchers enrolled 125 patients with MPM who suffered a relapse after chemotherapy. They divided the patients into two groups: one took the immunotherapy drug Opdivo, and the other took a different immunotherapy drug called Yervoy. THE STATS Tumors shrunk in 18% of the patients who took Opdivo, while 26% o
Baca selengkapnya

The Four Types of Mesothelioma

Mesothelioma is a type of cancer caused by exposure to asbestos. Asbestos is a naturally occurring mineral that is resistant to heat, fire, and other chemicals. There are four types of mesothelioma: lung, abdomen, heart, and testicular. LUNG: PLEURAL MESOTHELIOMA The most common type of mesothelioma, accounting for nearly 75% of all mesothelioma diagnoses. Pleural mesothelioma develops in the lining of the lungs, which is called the mesothelial. Symptoms vary from patient to patient, but some of the most common include: Shortness of breath Fatigue Difficulty swallowing Night sweats and fever Persistent dry cough Chest pain ABDOMEN: PERITONEAL MESOTHELIOMA Peritoneal mesothelioma is the second most common type of mesothelioma. It develops in the mesothelial lining of the abdomen. This type spreads faster than any other type, making treatment difficult. Common symptoms include: Abdominal pain or swelling Weight loss Fatigue Constipation or diarrhea Nausea and vo
Baca selengkapnya

New Treatment May Offer Hope to Mesothelioma Victims

A new, non-invasive cancer treatment has been approved by the U.S. Food and Drug Administration (FDA). NovoTTF-100L is the first treatment in more than 15 years to be approved by the FDA for malignant pleural mesothelioma (MPM). MPM is an aggressive form of cancer which cannot be surgically removed and has spread either outside the organ where it began (typically the lungs) or to other areas of the body. NovoTTF-100L works by delivering Tumor Treating Fields – electric fields tuned to specific frequencies that disrupt cell division – to the area of the body where the cancerous tumor is located. MPM Strongly Linked to Asbestos Exposure Obviously, the FDA approval is good news for victims of MPM, a devastating cancer that has been strongly linked to asbestos exposure. Approximately 3,000 people are diagnosed with MPM in the United States annually, with only 10-20 percent of them candidates for surgery to remove the tumor. Following asbestos exposure, it typically takes more than 2
Baca selengkapnya